Back to Trades
Other4
IONIS PHARMACEUTICALS INC
IONS
Total Value
$1.5M
Company Information
- Company Name
- IONIS PHARMACEUTICALS INC
- Ticker Symbol
- IONS
- CIK
- 0000874015
Insider Information
- Name
- Schneider Eugene
- Role
- EVP, Chf Clinical Develop Ofcr
- Location
- CARLSBAD, CA
Officer
Filing Details
- Filing Date
- Jan 6, 2026
- Transaction Date
- Jan 2, 2026
- Accession Number
- 0000874015-26-000025
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Derivative | 19,350 | $79.67 | Grant/Award | $1.5M |
Footnotes
- (F1)Grant on 01/02/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2026. 25% of the shares subject to the option will vest and become exercisable on 01/02/2027. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.